Skip to product information
Retatrutide is a "triple agonist" peptide currently in Phase 3 clinical trials that targets three hormone receptors—GLP-1, GIP, and glucagon—to
provide what some researchers call "surgical-level" weight loss results.
New Gpl phase 3 RTR 50 units
$300.00
Reliable shipping
Flexible returns
Compounded GLP-1 "shots" are custom-mixed versions
Retatrutide is a "triple agonist" peptide currently in Phase 3 clinical trials that targets three hormone receptors—GLP-1, GIP, and glucagon—to
Core Health Benefits
- Significant Weight Loss: In clinical trials, participants on the highest doses (12 mg) lost an average of 24% to 30% of their total body weight over 48 to 68 weeks.
- Reversal of Fatty Liver: Approximately 90% of trial participants with fatty liver disease saw their liver fat return to normal levels (below 5%) after 48 weeks of treatment.
- Improved Glycemic Control: Nearly 72% of participants with prediabetes achieved normal blood sugar levels, and those with Type 2 diabetes saw significant reductions in A1C.
- Osteoarthritis Relief: Patients with knee osteoarthritis reported a 75.8% reduction in painand significant improvements in physical function.
- Cardiovascular Improvements: Research indicates beneficial changes in blood pressure and cholesterol levels, with some participants able to discontinue blood pressure medications.
Metabolic & Psychological Benefits
- Increased Energy Expenditure: Unlike other medications that only suppress appetite, the glucagon component in retatrutide increases the body's resting metabolic rate, helping it burn more fat even at rest.
- Reduced "Food Noise": Many users report a significant reduction in constant thoughts about food and cravings, leading to a greater sense of control over eating habits.
- Better Energy Levels: Trial participants frequently reported feeling "lighter" with more stable energy throughout the day and improved mobility for physical activities.
- Preservation of Muscle Mass: Early data suggest that retatrutide may help preserve lean muscle mass similarly to other weight-loss treatments while focusing more aggressively on fat loss